AR095528A1 - INTERLEUCIN-22 (IL-22) POLYPEPTIDES AND IL-22 FUSION PROTEINS WITH HEAVY CHAIN FRAGMENT FC (IL-22 FC) AND METHODS OF USE - Google Patents
INTERLEUCIN-22 (IL-22) POLYPEPTIDES AND IL-22 FUSION PROTEINS WITH HEAVY CHAIN FRAGMENT FC (IL-22 FC) AND METHODS OF USEInfo
- Publication number
- AR095528A1 AR095528A1 ARP140101136A ARP140101136A AR095528A1 AR 095528 A1 AR095528 A1 AR 095528A1 AR P140101136 A ARP140101136 A AR P140101136A AR P140101136 A ARP140101136 A AR P140101136A AR 095528 A1 AR095528 A1 AR 095528A1
- Authority
- AR
- Argentina
- Prior art keywords
- methods
- polypeptides
- fusion proteins
- interleucin
- heavy chain
- Prior art date
Links
Abstract
Se refiere a polipéptidos de IL-22, proteínas de fusión de IL-22 Fc y agonistas de IL-22, composición que los comprende, métodos de fabricación y métodos de utilización de la composición para el tratamiento de enfermedades. También se refiere al receptor de IL-22 asociado a reactivos y métodos de uso de los mismos. Reivindicación 11: Una proteína de fusión de IL-22 de Fc que comprende un polipéptido de IL-22 unido a una región Fc de IgG mediante un ligador, en donde la región Fc comprende una región bisagra, un dominio CH2 de IgG y un dominio CH3 de IgG, y en donde la región Fc no está glicosilada.It refers to IL-22 polypeptides, IL-22 Fc fusion proteins and IL-22 agonists, composition comprising them, manufacturing methods and methods of using the composition for the treatment of diseases. It also refers to the IL-22 receptor associated with reagents and methods of use thereof. Claim 11: An Fc IL-22 fusion protein comprising an IL-22 polypeptide linked to an IgG Fc region by a linker, wherein the Fc region comprises a hinge region, a CH2 IgG domain and a domain. CH3 of IgG, and where the Fc region is not glycosylated.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361800148P | 2013-03-15 | 2013-03-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR095528A1 true AR095528A1 (en) | 2015-10-21 |
Family
ID=56119117
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP140101136A AR095528A1 (en) | 2013-03-15 | 2014-03-14 | INTERLEUCIN-22 (IL-22) POLYPEPTIDES AND IL-22 FUSION PROTEINS WITH HEAVY CHAIN FRAGMENT FC (IL-22 FC) AND METHODS OF USE |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR095528A1 (en) |
| MA (1) | MA38497B1 (en) |
-
2014
- 2014-03-14 AR ARP140101136A patent/AR095528A1/en unknown
- 2014-03-14 MA MA38497A patent/MA38497B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA38497B1 (en) | 2018-11-30 |
| MA38497A1 (en) | 2017-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20211272A1 (en) | IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE | |
| CO2019003945A2 (en) | Bispecific heterodimeric fusion proteins containing fc il-15 / il-15rα fusion proteins and pd-1 antibody fragments | |
| CL2017002761A1 (en) | Fusion proteins | |
| EA201591407A1 (en) | ANTIBODIES CONTAINING CHEMICAL CONSTANT DOMAINS | |
| CL2017002244A1 (en) | Specific bispecific antibodies for fap and dr5, specific antibodies for dr5 and methods of use. (divisional application 2829-2015). | |
| CO2017008047A2 (en) | Polypeptides that bind to proteins of the tumor necrosis factor receptor superfamily | |
| AR095432A1 (en) | PROTEINS OF UNION TO ANTIGEN | |
| EA201591700A1 (en) | HYBRID PROTEINS APELINA AND THEIR APPLICATION | |
| AR099288A1 (en) | INTERLEUCINE FUSION PROTEINS-10 | |
| BR112016002219A2 (en) | stabilization of fc-containing polypeptides | |
| CR20130621A (en) | ANTI-ANGPTL3 ANTIBODIES AND USES OF THE SAME | |
| EA201490745A1 (en) | POLYPEPTIDES OF ANTIBODIES THAT CAUSE ANTAGONISM CD40L | |
| AR098465A1 (en) | ANTI-a-SINUCLEINE ANTIBODIES AND METHODS OF USE | |
| EA201500741A1 (en) | HUMAN FG IGG1 OPTIONS AND THEIR APPLICATION | |
| CR20110544A (en) | SPECIFIC ANTAGONIST ANTIBODY FOR THE ALFA-4-BETA-7 HETERODYMER | |
| BR112016016411A2 (en) | "Fc"-REGION VARIANTS WITH MODIFIED "FcRn" BINDING PROPERTIES | |
| ES2694564T3 (en) | Interleukin-2 mutant polypeptides | |
| UY30324A1 (en) | RAGE FUSION PROTEINS, FORMULATIONS AND METHODS OF USE | |
| EA201990822A1 (en) | IMMUNOMODULATING FUSION PROTEINS | |
| UA117493C2 (en) | HYBRID CONSTRUCTION INCLUDING AN ANTIGEN-SPECIFIC FRAGMENT SPECIFIC TO SERUM ALBUMIN AND AN EFFECTIVE COMPONENT AND METHODS | |
| EA201691548A1 (en) | EXPRESSING STRUCTURES AND METHODS FOR SELECTION OF CELL HOSPITALS EXPRESSING POLYPEPTIDES | |
| ES2721935T3 (en) | Anti-BAG3 antibodies for therapeutic use | |
| UY37752A (en) | PROTEINS OF UNION TO THE ANTIGEN ANTI-JAGGED1 | |
| EA202090838A1 (en) | IMMUNOMODULATING FUSION PROTEINS | |
| CR20150477A (en) | IL-22 POLYPEPTIDES AND IL-22 FC FUSION PROTEINS AND METHODS OF USE |